New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Notch-1 and Notch-4 Receptors as Prognostic Markers in Breast Cancer
Notch-1 and Notch-4 Receptors as Prognostic Markers in Breast Cancer INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY Yao, K., Rizzo, P., Rajan, P., Albain, K., Rychlik, K., Shah, S., Miele, L. 2011; 19 (5): 607-613Abstract
Studies looking at immunohistochemical (IHC) staining of Notch receptors in breast cancer and correlation with known prognostic factors are sparse.IHC staining for nuclear, cytoplasmic, and membrane Notch-1 (N1), Notch-4 (N4), and Jagged-1 (JAG1) was performed and correlated with known prognostic factors.Of 48 breast cancers, 36 (67%) were invasive, mean age was 50 years (range 43-86 years), 37 (77%) were estrogen receptor (ERa) positive, and 13 (27%) node positive. There was significantly more marked N1 membranous staining in ERa-positive tumors (P < .05). On univariate analysis, cytoplasmic N1 was significantly correlated with node status and tumor grade (P < .05); both cytoplasmic and membranous N4 significantly correlated with Ki67 (P < .05); and membranous JAG1 significantly correlated with Ki67 (P < .05). On multivariate analysis, only cytoplasmic N1 significantly correlated with node status.IHC of Notch markers is feasible and correlates with known prognostic factors consistent with a biological role of Notch signaling in breast cancer progression.
View details for DOI 10.1177/1066896910362080
View details for Web of Science ID 000297077900008
View details for PubMedID 20444726